missouri medicaid glp 1 GLP-1 coverage for obesity treatment in 13 US states' programs Mapping the effectiveness and risks

And if you increase your muscle mass, youll burn more calories, even at rest

Accordingly, moderate lean tissue decline observed during GLP-1RA-induced weight loss could be interpreted as a physiological component of body composition change rather than evidence of pathological sarcopenia, unless accompanied by functional deterioration

Conversely, transplanting the microbiome from a healthy twin drives weight loss

It is not approved for any use as of June 2026, so eligibility is defined by the trials, not by a label

Future trials should prioritize sufficient duration ( 1218 months), include high-risk subgroups (e.g., older adults, frail individuals, patients with rapid or marked weight loss, or chronic comorbidities such as chronic kidney disease), and integrate nutritional and resistance training interventions

Yang, J., Wang, Z